Inventor · disambiguated record
Klaus Giese
Also filed as: GIESE KLAUS
29 granted patents·6 pending applications·826 citations·filing 1987–2020
97Inventor score
Files withSILENCE THERAPEUTICS GMBH11CHIRON CORP4SILENCE THERAPEUTICS AG AG4FEINSTEIN ELENA3NUVELO INC2
Top patents by PatentIndex Score
35 records- 0198US9695423B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2015·Granted Jul 4, 2017·46 cites·25 claims
- 0298US9222092B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2014·Granted Dec 29, 2015·76 cites·10 claims
- 0398US7741299B2Therapeutic uses of inhibitors of RTP801QUARK PHARMACEUTICALS INC·Filed 2005·Granted Jun 22, 2010·107 cites·12 claims
- 0498US7452987B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2003·Granted Nov 18, 2008·183 cites·7 claims
- 0597US8933215B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2012·Granted Jan 13, 2015·43 cites·19 claims
- 0697US7893245B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2008·Granted Feb 22, 2011·80 cites·11 claims
- 0795US9790505B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Oct 17, 2017·10 cites·23 claims
- 0895US8324370B2Interfering RNA moleculesGIESE KLAUS·Filed 2011·Granted Dec 4, 2012·46 cites·23 claims
- 0992US9790501B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Oct 17, 2017·6 cites·30 claims
- 1092US9758784B1Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Sep 12, 2017·6 cites·24 claims
- 1191US9783802B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Oct 10, 2017·5 cites·28 claims
- 1287US8309532B2Therapeutic uses of inhibitors of RTP801FEINSTEIN ELENA·Filed 2010·Granted Nov 13, 2012·7 cites·9 claims
- 1387US5291366ASurge voltage arresterASEA BROWN BOVERI·Filed 1992·Granted Mar 1, 1994·53 cites·7 claims
- 1486US10329568B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Jun 25, 2019·2 cites·24 claims
- 1586US10323246B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Jun 18, 2019·2 cites·30 claims
- 1686US10266829B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Apr 23, 2019·2 cites·23 claims
- 1782US6468790B1Metastatic breast and colon cancer regulated genesCHIRON CORP·Filed 2000·Granted Oct 22, 2002·6 cites·9 claims
- 1880US5747338AMethod and construct for screening for inhibitors of transcriptional activationCHIRON CORP·Filed 1996·Granted May 5, 1998·68 cites·45 claims
- 1979US6964868B1Human genes and gene expression products IINUVELO INC·Filed 1999·Granted Nov 15, 2005·35 cites·9 claims
- 2078US10774332B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2019·Granted Sep 15, 2020·0 cites·24 claims
- 2177US11578328B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2020·Granted Feb 14, 2023·0 cites·13 claims
- 2276US8168607B2Methods of treating eye diseases in diabetic patientsFEINSTEIN ELENA·Filed 2010·Granted May 1, 2012·2 cites·10 claims
- 2373US8642571B2Therapeutic uses of inhibitors of RTP801FEINSTEIN ELENA·Filed 2012·Granted Feb 4, 2014·1 cites·19 claims
- 2472US7279307B2Metastatic breast and colon cancer regulated genesCHIRON CORP·Filed 2003·Granted Oct 9, 2007·1 cites·26 claims
- 2570US7795407B2Metastatic breast and colon cancer regulated genesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Sep 14, 2010·0 cites·7 claims
- 2669US9133515B2Use of VEGFR1 as a biomarkerSILENCE THERAPEUTICS AG·Filed 2013·Granted Sep 15, 2015·1 cites·4 claims
- 2763US6635748B2Metastatic breast and colon cancer regulated genesCHIRON CORP·Filed 1998·Granted Oct 21, 2003·10 cites·9 claims
- 2853US7122373B1Human genes and gene expression products VNUVELO INC·Filed 1999·Granted Oct 17, 2006·14 cites·8 claims
- 2952US2005043263A1Use of double-stranded ribonucleic acid for inducing cell lysisATUGEN AG·Filed 2004·Application pending·0 cites
- 3051US2002009739A1Metastatic breast and colon cancer regulated genesFiled 2001·Application pending·0 cites
- 3150US4796283ASurge counter for an overvoltage arresterBBC BROWN BOVERI & CIE·Filed 1987·Granted Jan 3, 1989·14 cites·9 claims
- 3249US2003135033A1Compounds and methods for the identification and/ or validation of a targetFiled 2003·Application pending·0 cites
- 3344US2003158109A1Metastatic breast and colon cancer regulated genesFiled 2002·Application pending·0 cites
- 3442US2015368650A1Use of vegfr1 as a biomarkerSILENCE THERAPEUTICS GMBH·Filed 2015·Application pending·0 cites
- 3538US2002076735A1Diagnostic and therapeutic methods using molecules differentially expressed in cancer cellsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus Giese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →